BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25409603)

  • 1. Nanotechnology for in vivo targeted siRNA delivery.
    Dahlman JE; Kauffman KJ; Langer R; Anderson DG
    Adv Genet; 2014; 88():37-69. PubMed ID: 25409603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in nanoparticle-mediated siRNA delivery.
    Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
    Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of the systemic delivery of small interfering RNA.
    Ifediba MA; Moore A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):428-37. PubMed ID: 22228711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes.
    Leus NG; Talman EG; Ramana P; Kowalski PS; Woudenberg-Vrenken TE; Ruiters MH; Molema G; Kamps JA
    Int J Pharm; 2014 Jan; 459(1-2):40-50. PubMed ID: 24239833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent patents in siRNA delivery employing nanoparticles as delivery vectors.
    Nimesh S
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):91-7. PubMed ID: 22670609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
    Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
    J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.
    Kim YD; Park TE; Singh B; Maharjan S; Cho KS; Park KP; Choi YJ; Arote RB; Cho CS
    Curr Pharm Des; 2015; 21(31):4637-56. PubMed ID: 26486148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern.
    Ding W; Wang F; Zhang J; Guo Y; Ju S; Wang H
    Nanotechnology; 2013 Sep; 24(37):375101. PubMed ID: 23965897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
    Kapoor M; Burgess DJ; Patil SD
    Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attacking the genome: emerging siRNA nanocarriers from concept to clinic.
    Alabi C; Vegas A; Anderson D
    Curr Opin Pharmacol; 2012 Aug; 12(4):427-33. PubMed ID: 22726555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
    de Martimprey H; Vauthier C; Malvy C; Couvreur P
    Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.
    Gomes-da-Silva LC; Fernández Y; Abasolo I; Schwartz S; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
    Nanomedicine (Lond); 2013 Sep; 8(9):1397-413. PubMed ID: 23394132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.